BDNF and Headache: For biomarkers in our study with significantly lower levels in EM and/or CM patients compared to controls (NGF, BDNF, and PGE2), one common possible explanation, at least for EM patients perhaps, could be that the minimum 72-hour lag between headache onset and blood collection may have been too long, and resulted in sizeable drops from peak levels during attacks.